BCEL
Price:
$0.09
Market Cap:
$3.57M
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, and breast cancer samples from multiple patients. It also developing APN-122597, a receptor tyrosine kinase that target tumor tissues; and ATRC-501/MAM01, that targets the circumsporozoite protein of Plasmodium falciparum for the treatment of malaria...[Read more]
Industry
Biotechnology
IPO Date
2019-06-20
Stock Exchange
NASDAQ
Ticker
BCEL
According to Atreca, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.58. This represents a change of -55.07% compared to the average of 3.53 of the last 4 quarters.
The mean historical Current Ratio of Atreca, Inc. over the last ten years is 14.31. The current 1.58 Current Ratio has changed 1.01% with respect to the historical average. Over the past ten years (40 quarters), BCEL's Current Ratio was at its highest in in the September 2020 quarter at 28.48. The Current Ratio was at its lowest in in the March 2018 quarter at 0.
Average
14.31
Median
12.98
Minimum
4.79
Maximum
25.70
Discovering the peaks and valleys of Atreca, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 120.47%
Maximum Annual Current Ratio = 25.70
Minimum Annual Increase = -49.37%
Minimum Annual Current Ratio = 4.79
Year | Current Ratio | Change |
---|---|---|
2022 | 4.79 | -33.87% |
2021 | 7.24 | -49.37% |
2020 | 14.30 | -35.46% |
2019 | 22.16 | -13.75% |
2018 | 25.70 | 120.47% |
The current Current Ratio of Atreca, Inc. (BCEL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.78
5-year avg
14.84
10-year avg
14.31
Atreca, Inc.’s Current Ratio is less than Passage Bio, Inc. (7.67), less than Homology Medicines, Inc. (4.19), less than Stoke Therapeutics, Inc. (6.67), less than TCR2 Therapeutics Inc. (2.96), less than Revolution Medicines, Inc. (15.42), less than Black Diamond Therapeutics, Inc. (6.87), less than Harpoon Therapeutics, Inc. (1.89), less than Alector, Inc. (3.52),
Company | Current Ratio | Market cap |
---|---|---|
7.67 | $43.48M | |
4.19 | $3.02M | |
6.67 | $773.92M | |
2.96 | $58.11M | |
15.42 | $6.99B | |
6.87 | $305.13M | |
1.89 | $865.08M | |
3.52 | $472.01M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atreca, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Atreca, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Atreca, Inc.'s Current Ratio?
How is the Current Ratio calculated for Atreca, Inc. (BCEL)?
What is the highest Current Ratio for Atreca, Inc. (BCEL)?
What is the 3-year average Current Ratio for Atreca, Inc. (BCEL)?
What is the 5-year average Current Ratio for Atreca, Inc. (BCEL)?
How does the current Current Ratio for Atreca, Inc. (BCEL) compare to its historical average?